Cargando…
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma
We report the first evaluation of plant-made conjugate vaccines for targeted treatment of B-cell follicular lymphoma (FL) in a Phase I safety and immunogenicity clinical study. Each recombinant personalized immunogen consisted of a tumor-derived, plant-produced idiotypic antibody (Ab) hybrid compris...
Autores principales: | Tusé, Daniel, Ku, Nora, Bendandi, Maurizio, Becerra, Carlos, Collins, Robert, Langford, Nyla, Sancho, Susana Inogés, López-Díaz de Cerio, Ascensión, Pastor, Fernando, Kandzia, Romy, Thieme, Frank, Jarczowski, Franziska, Krause, Dieter, Ma, Julian K.-C., Pandya, Shan, Klimyuk, Victor, Gleba, Yuri, Butler-Ransohoff, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575747/ https://www.ncbi.nlm.nih.gov/pubmed/26425548 http://dx.doi.org/10.1155/2015/648143 |
Ejemplares similares
-
CD28 Aptamers as Powerful Immune Response Modulators
por: Pastor, Fernando, et al.
Publicado: (2013) -
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016) -
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
por: Wimmers, Florian, et al.
Publicado: (2017) -
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
por: Waerlop, Gwenn, et al.
Publicado: (2023) -
Quick and Clean Cloning: A Ligation-Independent Cloning Strategy for Selective Cloning of Specific PCR Products from Non-Specific Mixes
por: Thieme, Frank, et al.
Publicado: (2011)